The Claim
In bovine hepatocytes, exposure to sodium acetate at concentrations of 3.6–7.2 mM is associated with reduced expression and transcriptional activity of sterol regulatory element-binding protein 1c (SREBP-1c) and carbohydrate responsive element-binding protein (ChREBP), resulting in decreased expression of lipogenic genes such as acetyl-CoA carboxylase 1 (ACC1), fatty acid synthase (FAS), and stearoyl-CoA desaturase-1 (SCD-1), which suggests suppression of fatty acid synthesis.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
When cow liver cells are exposed to certain levels of sodium acetate, it seems to turn down the activity of genes involved in making fat, which might mean less fat is produced in those cells.
See the scientific wording
In bovine hepatocytes, exposure to 3.6–7.2 mM sodium acetate is associated with reduced expression and transcriptional activity of sterol regulatory element-binding protein 1c (SREBP-1c) and carbohydrate responsive element-binding protein (ChREBP), leading to decreased expression of lipogenic genes including ACC1, FAS, and SCD-1, suggesting suppression of fatty acid synthesis.
What the research says
1 studyThe study shows that treating cow liver cells with sodium acetate reduces the activity of key genes that make fat, which matches the claim.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.